SIG Brokerage’s Health Catalyst HCAT Stock Holding History

SIG Brokerage’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$37.9K	Hold	19,037	–	–	﹤0.01%	898
2026 Q1	$24.2K	Buy	+19,037	New	+$35.8K	﹤0.01%	763

Other funds holding HCAT

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

CDC Financial Chicago, Illinois $239M AUM

PVM

Palogic Value Management Dallas, Texas $304M AUM 15.15% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SIG Brokerage's HCAT Position: Q2 2026 in Review

SIG Brokerage held its Health Catalyst (HCAT) position steady in Q2 2026 at 19,037 shares worth $37.9K. The position accounts for ﹤0.01% of the portfolio, ranked #898.

SIG Brokerage first reported a position in HCAT in Q1 2026 and has held it in 2 quarters since. 127 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

SIG Brokerage held 19,037 shares of Health Catalyst worth $37.9K as of Q2 2026.
SIG Brokerage left its Health Catalyst share count unchanged in Q2 2026.
Health Catalyst made up ﹤0.01% of SIG Brokerage's portfolio in Q2 2026, its #898 holding.
SIG Brokerage first reported a position in Health Catalyst in Q1 2026 and has held it in 2 quarters since.
127 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on SIG Brokerage's 13F filing for Q2 2026, filed 14 Aug 2026.